Early MiscarriageNCT07406776
Identification of Histories of Pregnancy Termination, Particularly Early Miscarriage, in General Medical Records
An observational study of Early Miscarriage, run by Université de Reims Champagne-Ardenne at 1 site in France.
Trial summary
Early miscarriage (EM) is defined as the spontaneous expulsion of an intrauterine pregnancy of less than 14 weeks' duration. Early miscarriage is a very common complication, affecting more than 10% of pregnancies. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Early Miscarriage
- How many people
- 145 participants
- Where
- 1 siteFrance
- Study dates
- 16 May 2025to 5 Feb 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Women aged between 18 and 50, who declared a GP participating in the study as their GP and agreed to take part in the study.
Who may be able to join
- Female
- Aged between 18 and 50
- Whose GP has agreed to take part in the study
- Agreeing to take part in the study.
Who cannot join
- Minors
- Over the age of 50
- Protected by law (guardianship, curatorship, safeguard of justice)
- Refusing to take part in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Early miscarriage (EM) is defined as the spontaneous expulsion of an intrauterine pregnancy of less than 14 weeks' duration. Early miscarriage is a very common complication, affecting more than 10% of pregnancies. Because of its frequency, EM is often considered a trivial event, particularly by healthcare professionals.
However, for the women who experience it, EM can be a traumatic event, difficult to discuss with their families, and a source of worries and questions for subsequent pregnancies. The international literature is consistent on the psychological morbidity associated with miscarriage: anxiety, depression and post-traumatic stress disorder have been studied in women following CPT. The identification of a history of EM by doctors is therefore important for the overall management of women's health.
The 2021 National Perinatal Survey showed that less than 5% of pregnant women in France had their first six months of pregnancy monitored by a general practitioner, a proportion that has been steadily declining in recent years. The majority of women are monitored by a gynecologist, or in 40% of cases by a midwife. These professionals therefore appear to be the preferred point of contact for women in the event of a miscarriage. In the absence of specific information, either from the woman herself or from the healthcare professional who treated her, the general practitioner-the attending physician may remain unaware of this event in their patient's life. Under these circumstances, identifying a history of EM in the general practitioner's medical records may not be sufficient.
Read the detailed description
The primary objective is to describe the frequency of notification of a history of early miscarriage in the treating physician's medical record.
The secondary objectives are :
- To describe how the treating physician is informed of the history of early miscarriage.
- To investigate the factors associated with notification of a history of early miscarriage in the treating physician's medical record medical records.
- Describe the frequency of notification of a history of termination of pregnancy other than early miscarriage (voluntary termination of pregnancy, foetal death in utero, medical termination of pregnancy) in the treating physician's medical record.
- Describe the procedures for informing the attending doctor about the history of termination of pregnancy other than early miscarriage.
- Conditions
- Early Miscarriage
- Keywords
- early miscarriage, termination pregnancy, general medical
- Medical subject headings
- Abortion, Spontaneous
What is being measured
The primary outcome is the main question the study is designed to answer.
notification of early miscarriage in the medical file of the woman who reported it.
the frequency of notification of a history of early miscarriage in the attending physician's medical records.
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2026
- Study start16 May 2025
- Primary completion27 Nov 2025
- Study completion5 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Early MiscarriageStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 145 participants (actual)
Sponsor and investigators
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07406776
- Sponsor's protocol ID
- 2024_RIPH_07_DMG-Fausse couche
- Status last verified
- Feb 2026
- First submitted
- 5 Feb 2026
- Last updated
- 17 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identification of Histories of Pregnancy Termination, Particularly Early Miscarriage, in General Medical Records
- ClinicalTrials.gov ID
- NCT07406776
- Acronym / sponsor ID
- 2024_RIPH_07_DMG-Fausse couche
- Conditions
- Early Miscarriage
- Keywords
- early miscarriage, termination pregnancy, general medical
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 145 participants (actual)
- Lead sponsor
- Université de Reims Champagne-ArdenneUniversity, hospital or other
- Study start
- 16 May 2025 (actual)
- Primary completion
- 27 Nov 2025 (actual)
- Study completion
- 5 Feb 2026 (actual)
- First posted
- 12 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Early miscarriage (EM) is defined as the spontaneous expulsion of an intrauterine pregnancy of less than 14 weeks' duration. Early miscarriage is a very common complication, affecting more than 10% of pregnancies. Because of its frequency, EM is often considered a trivial event, particularly by healthcare professionals.
However, for the women who experience it, EM can be a traumatic event, difficult to discuss with their families, and a source of worries and questions for subsequent pregnancies. The international literature is consistent on the psychological morbidity associated with miscarriage: anxiety, depression and post-traumatic stress disorder have been studied in women following CPT. The identification of a history of EM by doctors is therefore important for the overall management of women's health.
The 2021 National Perinatal Survey showed that less than 5% of pregnant women in France had their first six months of pregnancy monitored by a general practitioner, a proportion that has been steadily declining in recent years. The majority of women are monitored by a gynecologist, or in 40% of cases by a midwife. These professionals therefore appear to be the preferred point of contact for women in the event of a miscarriage. In the absence of specific information, either from the woman herself or from the healthcare professional who treated her, the general practitioner-the attending physician may remain unaware of this event in their patient's life. Under these circumstances, identifying a history of EM in the general practitioner's medical records may not be sufficient.
Detailed description
The primary objective is to describe the frequency of notification of a history of early miscarriage in the treating physician's medical record.
The secondary objectives are :
- To describe how the treating physician is informed of the history of early miscarriage.
- To investigate the factors associated with notification of a history of early miscarriage in the treating physician's medical record medical records.
- Describe the frequency of notification of a history of termination of pregnancy other than early miscarriage (voluntary termination of pregnancy, foetal death in utero, medical termination of pregnancy) in the treating physician's medical record.
- Describe the procedures for informing the attending doctor about the history of termination of pregnancy other than early miscarriage.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Women aged between 18 and 50, who declared a GP participating in the study as their GP and agreed to take part in the study.
Key inclusion criteria (4 listed)
- Female
- Aged between 18 and 50
- Whose GP has agreed to take part in the study
- Agreeing to take part in the study.
Key exclusion criteria (4 listed)
- Minors
- Over the age of 50
- Protected by law (guardianship, curatorship, safeguard of justice)
- Refusing to take part in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
notification of early miscarriage in the medical file of the woman who reported it.
Time frame: Day 0
the frequency of notification of a history of early miscarriage in the attending physician's medical records.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2026.
Related trials for Early Miscarriage
Not yet recruiting
Virtual Reality for Pain and Anxiety During Surgical Uterine Evacuation After Early Pregnancy Loss
Early Pregnancy Loss, Procedural Pain
Recruiting
The Psychological Effects of Miscarriage Prediction Score: A Prospective Study
Early Pregnancy Bleeding
Not yet recruitingPhase 3
Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy Loss
Pregnancy Loss, Pregnancy Loss, Early
Not yet recruitingPhase 3
Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
Early Pregnancy Loss
Recruiting
GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA
Miscarriage in First Trimester, Prenatal Genetic Diagnosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Early Miscarriage, run by Université de Reims Champagne-Ardenne at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
notification of early miscarriage in the medical file of the woman who reported it. (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.